550 related articles for article (PubMed ID: 30628661)
1. Cancer-associated stroke: Pathophysiology, detection and management (Review).
Dardiotis E; Aloizou AM; Markoula S; Siokas V; Tsarouhas K; Tzanakakis G; Libra M; Kyritsis AP; Brotis AG; Aschner M; Gozes I; Bogdanos DP; Spandidos DA; Mitsias PD; Tsatsakis A
Int J Oncol; 2019 Mar; 54(3):779-796. PubMed ID: 30628661
[TBL] [Abstract][Full Text] [Related]
2. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant tissue plasminogen activator in cancer patients with acute stroke.
Graber JJ; Nayak L; Deangelis LM
J Neurooncol; 2012 May; 107(3):571-3. PubMed ID: 22179814
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants--a frequent challenge for the emergency management of acute ischemic stroke.
Rizos T; Horstmann S; Jenetzky E; Spindler M; Gumbinger C; Möhlenbruch M; Ringleb P; Hacke W; Veltkamp R
Cerebrovasc Dis; 2012; 34(5-6):411-8. PubMed ID: 23221347
[TBL] [Abstract][Full Text] [Related]
5. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator.
Fassbender K; Dempfle CE; Mielke O; Schwartz A; Daffertshofer M; Eschenfelder C; Dollman M; Hennerici M
Stroke; 1999 Oct; 30(10):2101-4. PubMed ID: 10512913
[TBL] [Abstract][Full Text] [Related]
6. [Stroke and Cancer: Are Cryptogenic Strokes a Paraneoplastic Syndrome?].
Eschle D
Praxis (Bern 1994); 2015 Jul; 104(15):795-802. PubMed ID: 26204338
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
8. Safety of Intravenous Thrombolysis among Stroke Patients Taking New Oral Anticoagulants--Case Series and Systematic Review of Reported Cases.
Shahjouei S; Tsivgoulis G; Bavarsad Shahripour R; Jones GM; Alexandrov AV; Zand R
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2685-93. PubMed ID: 26542821
[TBL] [Abstract][Full Text] [Related]
9. Application of Neuroimaging for the Prediction of Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke.
Yang M; Tang L; Hu Z; Tang X
Cerebrovasc Dis; 2023; 52(1):1-10. PubMed ID: 35661647
[TBL] [Abstract][Full Text] [Related]
10. Recombinant tissue plasminogen activator (rtPA) for stroke. The perspective at 8 years.
Frey JL
Neurologist; 2005 Mar; 11(2):123-33. PubMed ID: 15733334
[TBL] [Abstract][Full Text] [Related]
11. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
12. Safety and outcome of rtPA in acute ischemic stroke in patients with active cancer: case-control study.
Geraldes T; Pereira L; Guarda C; Grunho M; Ribeiro AC; Coimbra J; Mendes I; Rodrigues M
Rev Neurol; 2017 Jul; 65(1):13-18. PubMed ID: 28650062
[TBL] [Abstract][Full Text] [Related]
13. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.
Kleindorfer D; Kissela B; Schneider A; Woo D; Khoury J; Miller R; Alwell K; Gebel J; Szaflarski J; Pancioli A; Jauch E; Moomaw C; Shukla R; Broderick JP;
Stroke; 2004 Feb; 35(2):e27-9. PubMed ID: 14739423
[TBL] [Abstract][Full Text] [Related]
14. [Atrial fibrillation in an acute stroke unit].
Melki E; Mawet J; Sarov-Riviere M; Bousser MG
Bull Acad Natl Med; 2011; 195(4-5):987-1000; discussion 1000-1. PubMed ID: 22375365
[TBL] [Abstract][Full Text] [Related]
15. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
[TBL] [Abstract][Full Text] [Related]
16. Extensive experience with dural sinus thrombosis.
Soleau SW; Schmidt R; Stevens S; Osborn A; MacDonald JD
Neurosurgery; 2003 Mar; 52(3):534-44; discussion 542-4. PubMed ID: 12590677
[TBL] [Abstract][Full Text] [Related]
17. Recurrent stroke in a patient of lung cancer without pulmonary mass: A case report.
Wang L; Xu Y; Tuo M; Zhang L; Zhang H; Wang J
Medicine (Baltimore); 2018 Feb; 97(5):e9815. PubMed ID: 29384885
[TBL] [Abstract][Full Text] [Related]
18. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients.
Brecthel L; Gainey J; Penwell A; Nathaniel TI
BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and management of acute ischemic stroke.
Bendixen BH; Ocava L
Curr Cardiol Rep; 2002 Mar; 4(2):149-57. PubMed ID: 11827639
[TBL] [Abstract][Full Text] [Related]
20. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
